Archives

by in
Entry Author Date Location
2014 Trends in Early-Stage Life Sciences Investment 02/20/14 Boston
East Coast Biotech Roundup: Voyager, Concert, Retrophin, & More 02/14/14 Boston
Concert Pharma Heads to Nasdaq, Prices IPO at $14 Per Share 02/13/14 Boston
Flexion Prices IPO at $13, Heads to Nasdaq Tomorrow 02/11/14 Boston
Boston Tech Roundup: DataXu, Imprivata, Flashnotes 02/07/14 Boston
East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More 02/07/14 Boston
San Diego Life Sciences Roundup: Auspex, Biocept, Halozyme & More 02/07/14 San Diego
Vaccine Developer Genocea Prices IPO at $12 Per Share 02/05/14 Boston
San Diego Life Sciences Roundup: Accelrys, Celladon’s IPO, and More 01/31/14 San Diego
East Coast Biotech Roundup: Dicerna, J&J, Neurophage, & More 01/31/14 Boston
Dicerna Shares Triple on First Trading Day, Close at $46 01/30/14 Boston
Dicerna Prices Upsized IPO at $15 Per Share, Starts Trading Thursday 01/29/14 Boston
Epizyme Heads Back to Wall Street, Plans $140M Raise 01/27/14 Boston
With Biotech IPO Outlet, San Diego Venture Funding at 15-Year Low 01/21/14 San Diego
Intercept Shares Skyrocket After Liver Drug Nails Mid-Stage Study 01/09/14 New York
Flexion Files for IPO, Seeks $86M to Develop Osteoarthritis Drugs 01/08/14 Boston
East Coast Biotech Roundup: Scholar Rock, Dicerna, Eleven, & More 01/03/14 Boston
Dicerna Joins Biotech IPO Queue, Plans $69M Raise 01/02/14 Boston
Tech Bubble Leaks Air, Healthcare Bests Biotech, & More for 2014 01/02/14 Boston
The Year in Innovation: Xconomy’s Top 13 Stories of 2013 12/31/13 National
Vaccine Developer Genocea Files For IPO, Plans to Raise $75M 12/23/13 Boston
Acucela Seeks $125M IPO in Japan to Develop Eye Drugs 12/17/13 Seattle
Care.com Seeks $80M IPO, Still Unprofitable 12/12/13 Boston
U.S. IPO Activity in 2013 on Track for Highest Level in 9 Years 12/11/13 San Diego
With $32M, Opscode Becomes ‘Chef’ and Serves ‘New IT’ Platform 12/09/13 Seattle
San Diego Life Sciences Roundup: Orexigen, Avalon, GSK, and More 11/27/13 San Diego
San Diego Life Sciences Roundup: IPOs, CareFusion, and More 11/22/13 San Diego
Vital Therapies Postpones IPO as Biotech Sector Chills 11/22/13 San Diego
As Total U.S. IPOs Mount, Several Biotech Deals Stumble 11/19/13 San Diego
The Biotech Startup Class of 2013: Don’t Worry, It’s a Short List 11/18/13 National
Page 3 of 16 « previous page · next page »